# Seuss\+: Strategy and Execution Experts for Vendor Challenges in Clinical Development

> Seuss\+ optimizes sponsor and vendor relationships so clinical trials stay on time and on budget\. 14 years, 55\+ biotech programs, hands\-on VRMM\.

Generated by Yoast SEO v28.2, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Project Assistant](https://www.seuss.plus/project-assistant-2/)
- [Speaking](https://www.seuss.plus/speaking/): Our thought leaders are passionate speakers with a unique view on topics varying from outsourcing relationships, to unleashing your inner leader, to employer branding and more
- [Privacy Policy](https://www.seuss.plus/privacy-policy/)
- [Careers at Seuss\+](https://www.seuss.plus/careers-at-seuss/)
- [Life Science Business Consultant](https://www.seuss.plus/business-consultant/)

## Posts
- [Avoiding Delays In Clinical Trials](https://www.seuss.plus/blog/avoiding-delays-in-clinical-trials/): Seuss\+ CEOs Sabine Hutchison, Kieran Engels, and Senior Business Consultant Nicolyn Liebenberg get together to answer the most frequently searched for questions on CRO \& Vendor Selection\. 
- [Introducing Noemi Paloczi: Thoughtful Coordination That Keeps Projects Moving](https://www.seuss.plus/blog/introducing-noemi-paloczi-thoughtful-coordination-that-keeps-projects-moving/): We’re excited to welcome Noemi to Seuss\+, where she joins the team in a project Assistant role\.
- [Part One: Clinical Trial Execution for Biotechs: Why Execution, not Strategy, Gets Things Done](https://www.seuss.plus/blog/part-one-clinical-trial-execution-for-biotechs-why-execution-not-strategy-gets-things-done/): In early\-stage biotech, clinical trial execution for biotechs is often treated as an “ops problem\.” But the truth? Execution is Strategy\.

## Projects
- [Safeguarding Data Integrity in a Phase 2 COPD Study](https://www.seuss.plus/project/safeguarding-data-integrity-in-a-phase-2-copd-study/): No data flow diagram\. No validation records from the CRO\. Here is how Seuss\+ mapped 14 systems across 7 vendors and gave the sponsor its oversight back\.
- [Negotiating Sponsor\-Friendly Contracts that Drive CRO Accountability \& Performance](https://www.seuss.plus/project/negotiating-sponsor-friendly-contracts-that-drive-cro-accountability-performance/): A privately\-owned rare disease biotech preparing for a global Phase 3 clinical trial faced significant contract challenges with its CRO\. Misaligned terms created limited leverage to enforce performance, slow responsiveness to operational issues, and exposure to budget overruns\. Seuss\+ was engaged to renegotiate contracts, protect the sponsor’s position, and establish governance structures to hold the CRO accountable\.
- [ Driving Operational Efficiency in a Respiratory Trial with Legacy CRO Constraints ](https://www.seuss.plus/project/driving-operational-efficiency-in-a-respiratory-trial-with-legacy-cro-constraints/): A discovery\-stage biotech in  Phase 2 development, was navigating early clinical demands while managing lean internal resources\. 
- [Strategic Vendor Oversight and Trial Support for a Pivotal Phase 3 CNS Program](https://www.seuss.plus/project/strategic-vendor-oversight-and-trial-support-for-a-pivotal-phase-3-cns-program/): A small biotech company preparing for a pivotal Phase 3 trial in a challenging CNS indication had selected a CRO with deep therapeutic insight but limited experience in complex global delivery\. The sponsor's internal team was lean, with functional gaps in oversight, vendor coordination, and contract governance\. When COVID\-19 introduced added risk, the need for hands\-on support became urgent\. Seuss\+ was brought in first to review a contract—then rapidly engaged to deliver fully integrated support across the trial lifecycle\.
- [Fully\-Integrated Vendor Management Support in Phase 2](https://www.seuss.plus/project/fully-integrated-vendor-management-support-in-phase-2/): A high\-potential biotech, entering Phase 2 with an ambitious formulation study, faced late\-stage strategic changes that rendered its original CRO unsuitable\. Operating with a lean team and under competitive pressures, the sponsor required rapid CRO transition, complete vendor oversight, and embedded operational expertise to stay on schedule and protect data integrity\.

## Type
- [section](https://www.seuss.plus/blog/layout_type/section/)
- [module](https://www.seuss.plus/blog/layout_type/module/)
- [row](https://www.seuss.plus/blog/layout_type/row/)
- [layout](https://www.seuss.plus/blog/layout_type/layout/)

## Module Width
- [regular](https://www.seuss.plus/blog/module_width/regular/)
- [fullwidth](https://www.seuss.plus/blog/module_width/fullwidth/)

## Scope
- [not\_global](https://www.seuss.plus/blog/scope/not_global/)
- [global](https://www.seuss.plus/blog/scope/global/)

## Optional
- [Sitemap index](https://www.seuss.plus/sitemap_index.xml)